Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology

PLoS Medicine

Volumn 3, Issue 7, 2006, Pages 1178-1186

  Smith, Thomas G ^a   Brooks, Jerome T ^a   Balanos, George M ^b   Lappin, Terence R ^c   Layton, D Mark ^d   Leedham, Dawn L ^e   Liu, Chun ^a   Maxwell, Patrick H ^d   McMullin, Mary F ^c   McNamara, Christopher J ^f   Percy, Melanie J ^c   Pugh, Christopher W ^g   Ratcliffe, Peter J ^g   Talbot, Nick P ^a   Treacy, Marilyn ^e   Robbins, Peter A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e CHASE FARM HOSPITAL   (United Kingdom)

^f ROYAL FREE HOSPITAL   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; VON HIPPEL LINDAU PROTEIN; CARBON DIOXIDE; FRUCTOSE BISPHOSPHATE ALDOLASE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IRON; OXYGEN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN; VHL PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD ANALYSIS; CARDIOPULMONARY FUNCTION; CHUVASH POLYCYTHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; HEART RATE; HUMAN; HYPOXIA; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; LUNG VENTILATION; MALE; MUTATIONAL ANALYSIS; POLYCYTHEMIA; SYSTEMIC VASCULAR RESISTANCE; VENOUS BLOOD; ADAPTATION; AEROSPACE MEDICINE; ALTITUDE; ANGIOGENESIS; ANOXIA; BIOSYNTHESIS; BLOOD; CARDIOVASCULAR FUNCTION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HOMOZYGOTE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSURE; PULMONARY HYPERTENSION; RESPIRATORY FUNCTION; TACHYCARDIA; VASOCONSTRICTION;

ADAPTATION, PHYSIOLOGICAL; ADOLESCENT; ADULT; AEROSPACE MEDICINE; ALTITUDE; ANOXIA; CARBON DIOXIDE; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE EXPRESSION REGULATION; HOMOZYGOTE; HUMANS; HYPERTENSION, PULMONARY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IRON; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; PARTIAL PRESSURE; POLYCYTHEMIA; PULMONARY VENTILATION; RESPIRATORY PHYSIOLOGICAL PHENOMENA; TACHYCARDIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOCONSTRICTION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 33746398489     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030290     Document Type: Article

References (44)

1. Semenza GL (2004) Hydroxylation of HIF-1: Oxygen sensing at the molecular level. Physiology (Bethesda) 19: 176-182.
2. Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275.
3. Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, et al. (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2: 423-427.
4. 2-regulated prolyl hydroxylation. Science 292: 468-472.
5. 2 sensing. Science 292: 464-468.
6. Paul SA, Simons JW, Mabjeesh NJ (2004) HIF at the crossroads between ischemia and carcinogenesis. J Cell Physiol 200: 20-30.
7. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, et al. (2003) von Hippel-Lindau disease. Lancet 361: 2059-2067.
8. Ang S, Chen H, Hirota K, Gordeuk V, Jelinek J, et al. (2002) Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32: 614-621.
9. Percy MJ, McMullin MF, Jowitt SN, Potter M, Treacy M, et al. (2003) Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. Blood 102: 1097-1099.
10. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
11. Robbins PA, Swanson GD, Howson MG (1982) A prediction-correction scheme for forcing alveolar gases along certain time courses. J Appl Physiol 52: 1353-1357.
12. Howson MG, Khamnei S, O'Connor DF, Robbins PA (1986) The properties of a turbine device for measuring respiratory volumes in man. J Physiol 382: 12P.
13. Yock PG, Popp RL (1984) Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70: 657-662.
14. Talbot NP, Balanos GM, Dorrington KL, Robbins PA (2005) Two temporal components within the human pulmonary vascular response to ∼2 h of isocapnic hypoxia. J Appl Physiol 98: 1125-1139.
15. Balanos GM, Talbot NP, Dorrington KL, Robbins PA (2003) Human pulmonary vascular response to 4 h of hypercapnia and hypocapnia measured using Doppler echocardiography. J Appl Physiol 94: 1543-1551.
16. Ghofrani HA, Reichenberger F, Kohstall MG, Mrosek EH, Seeger T, et al. (2004) Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: A randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med 141: 169-177.
17. Grunig E, Mereles D, Hildebrandt W, Swenson ER, Kubler W, et al. (2000) Stress doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol 35: 980-987.
18. Peacock AJ, Challenor V, Sutherland G (1990) Estimation of pulmonary artery pressure by Doppler echocardiography in normal subjects made hypoxic. Respir Med 84: 335-337.
19. Allemann Y, Sartori C, Lepori M, Pierre S, Melot C, et al. (2000) Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am J Physiol Heart Circ Physiol 279: H2013-H2016.
20. Chemla D, Castelain V, Humbert M, Hebert JL, Simonneau G, et al. (2004) New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 126: 1313-1317.
21. Groves BM, Reeves JT, Sutton JR, Wagner PD, Cymerman A, et al. (1987) Operation Everest II: Elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol 63: 521-530.
22. Farber HW, Loscalzo J (2004) Pulmonary arterial hypertension. N Engl J Med 351: 1655-1665.
23. Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, et al. (2004) Congenital disorder of oxygen sensing: Association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 103: 3924-3932.
24. Douglas CG, Haldane JS, Henderson Y, Schneider EC (1913) Physiological observations made on Pike's Peak, Colorado, with special reference to adaptation to low barometric pressure. Philos Trans R Soc Lond B Biol Sci B203:: 185-318.
25. Sato M, Severinghaus JW, Powell FL, Xu FD, Spellman MJ Jr (1992) Augmented hypoxic ventilatory response in men at altitude. J Appl Physiol 73: 101-107.
26. Corne S, Webster K, Younes M (2003) Hypoxic respiratory response during acute stable hypocapnia. Am J Respir Crit Care Med 167: 1193-1199.
27. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A (2001) Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 120: 801-808.
28. Saadjian A, Philip-Joet F, Levy S, Arnaud A (1992) Vascular and cardiac reactivity in pulmonary hypertension due to chronic obstructive lung disease: Assessment with various oxygen concentrations. Eur Respir J 5: 525-530.
29. Benumof JL, Wahrenbrock EA (1975) Blunted hypoxic pulmonary vasoconstriction by increased lung vascular pressures. J Appl Physiol 38: 846-850.
30. Dorrington KL, Clar C, Young JD, Jonas M, Tansley JG, et al. (1997) Time-course of the human pulmonary vascular response to 8 hours of isocapnic hypoxia. Am J Physiol 273: H1126-H1134.
31. Fried R, Meyrick B, Rabinovitch M, Reid L (1983) Polycythemia and the acute hypoxic response in awake rats following chronic hypoxia. J Appl Physiol 55: 1167-1172.
32. Bisgard GE, Alvarez HG, Grover RF (1969) Decreased ventilatory response to hypoxia during acute polycythemia in the calf. Respir Physiol 7: 369-382.
33. Eisele JH, Pegg J, Severinghaus JW (1969) Ventilatory response to hypoxia in acutely polycythemic dogs. J Appl Physiol 26: 757-759.
34. Clar C, Dorrington KL, Robbins PA (1999) Ventilatory effects of 8 hours of isocapnic hypoxia with and without beta-blockade in humans. J Appl Physiol 86: 1897-1904.
35. Heistad DD, Wheeler RC, Mark AL, Schmid PG, Abboud FM (1972) Effects of adrenergic stimulation on ventilation in man. J Clin Invest 51: 1469-1475.
36. Brimioulle S, Vachiery J, Brichant J, Delcroix M, Lejeune P, et al. (1997) Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs. Cardiovasc Res 34: 384-392.
37. Voelkel NF, Walker BR, Reeves JT (1984) Chronic propranolol treatment decreases pulmonary artery pressure in conscious dogs. Clin Physiol Biochem 2: 176-183.
38. Kline DD, Peng YJ, Manalo DJ, Semenza GL, Prabhakar NR (2002) Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. Proc Natl Acad Sci U S A 99: 821-826.
39. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, et al. (1999) Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest 103: 691-696.
40. Shimoda LA, Manalo DJ, Sham JSK, Semenza GL, Sylvester JT (2001) Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol Lung Cell Mol Physiol 281: L202-L208.
41. Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH, et al. (2003) Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 111: 1519-1527.
42. Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354.
43. Czyzyk-Krzeska MF, Bayliss DA, Lawson EE, Millhorn DE (1992) Regulation of tyrosine hydroxylase gene expression in the rat carotid body by hypoxia. J Neurochem 58: 1538-1546.
44. Soliz J, Joseph V, Soulage C, Becskei C, Vogel J, et al. (2005) Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies. J Physiol 568: 559-571.